{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:54:40Z","timestamp":1790326480781,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014569","name":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.farma.2024.12.003","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T15:22:39Z","timestamp":1737386559000},"page":"T230-T234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["[Translated article] Prospective observational follow-up study of psychoactive drug treatment initiated in the intensive care unit"],"prefix":"10.1016","volume":"49","author":[{"given":"Laura","family":"Dom\u00e9nech-Moral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Santader-Reboreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meri","family":"Martin-Cerezuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia Eg\u00fc\u00e9s","family":"Lugea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Buj","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda Contreras","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.farma.2024.12.003_bb0005","article-title":"Psychiatry's role in the prevention of post-intensive care mental health impairment: stakeholder survey","volume":"22","author":"Bieber","year":"2022","journal-title":"BMC Psychiatry [Internet]."},{"issue":"8","key":"10.1016\/j.farma.2024.12.003_bb0010","first-page":"292","article-title":"Psychiatric management of patients in intensive care units","volume":"64","author":"Phadke","year":"2022","journal-title":"Indian J Psychiatry [Internet]."},{"issue":"14","key":"10.1016\/j.farma.2024.12.003_bb0015","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1001\/jama.291.14.1753","article-title":"Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit","volume":"291","author":"Ely","year":"2004","journal-title":"JAMA [Internet]."},{"issue":"6","key":"10.1016\/j.farma.2024.12.003_bb0020","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1097\/CCM.0b013e31819ffe38","article-title":"The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients","volume":"37","author":"Lat","year":"2009","journal-title":"Crit Care Med [Internet]."},{"issue":"11","key":"10.1016\/j.farma.2024.12.003_bb0025","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/rccm.200904-0537OC","article-title":"Days of delirium are associated with 1-year mortality in an older intensive care unit population","volume":"180","author":"Pisani","year":"2009","journal-title":"Am J Respir Crit Care Med [Internet]."},{"issue":"5","key":"10.1016\/j.farma.2024.12.003_bb0030","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/147323001003800503","article-title":"Delayed treatment of delirium increases mortality rate in intensive care unit patients","volume":"38","author":"Heymann","year":"2010","journal-title":"J Int Med Res [Internet]."},{"issue":"10","key":"10.1016\/j.farma.2024.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1345\/aph.1Q332","article-title":"Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight states","volume":"45","author":"Devlin","year":"2011","journal-title":"Ann Pharmacother [Internet]."},{"issue":"6","key":"10.1016\/j.farma.2024.12.003_bb0040","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/CCM.0000000000000224","article-title":"Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis: a systematic review and meta-analysis","volume":"42","author":"Al-Qadheeb","year":"2014","journal-title":"Crit Care Med [Internet]."},{"issue":"3","key":"10.1016\/j.farma.2024.12.003_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0897190012465987","article-title":"Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium","volume":"26","author":"Jasiak","year":"2013","journal-title":"J Pharm Pract [Internet]."},{"key":"10.1016\/j.farma.2024.12.003_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcrc.2015.12.017","article-title":"Antipsychotic utilization in the intensive care unit and in transitions of care","volume":"33","author":"Marshall","year":"2016","journal-title":"J Crit Care [Internet]."},{"issue":"6","key":"10.1016\/j.farma.2024.12.003_bb0055","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jcrc.2015.08.009","article-title":"Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit","volume":"30","author":"Rowe","year":"2015","journal-title":"J Crit Care [Internet]."},{"issue":"4","key":"10.1016\/j.farma.2024.12.003_bb0060","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/M13-2796","article-title":"Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study: a population-based cohort study","volume":"161","author":"Hwang","year":"2014","journal-title":"Ann Intern Med [Internet]."},{"issue":"7","key":"10.1016\/j.farma.2024.12.003_bb0065","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7326\/0003-4819-152-7-201004060-00006","article-title":"Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case\u2013control study: a nested case\u2013control study","volume":"152","author":"Trifir\u00f2","year":"2010","journal-title":"Ann Intern Med [Internet]."},{"issue":"4","key":"10.1016\/j.farma.2024.12.003_bb0070","first-page":"674","article-title":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults: 2019 Ags beers criteria\u00ae update expert panel","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc [Internet]."},{"issue":"23 Suppl 3","key":"10.1016\/j.farma.2024.12.003_bb0075","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.2146\/ajhp150474","article-title":"Hospital delirium treatment: continuation of antipsychotic therapy from the intensive care unit to discharge","volume":"72","author":"Flurie","year":"2015","journal-title":"Am J Health Syst Pharm [Internet]."},{"issue":"3","key":"10.1016\/j.farma.2024.12.003_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/0897190016645026","article-title":"Continuation rate of atypical antipsychotics after discharge when initiated in the intensive care unit","volume":"30","author":"Farrokh","year":"2017","journal-title":"J Pharm Pract [Internet]."},{"issue":"3","key":"10.1016\/j.farma.2024.12.003_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.medin.2019.07.013","volume":"44","author":"Celis-Rodr\u00edguez","year":"2020","journal-title":"Med Intensiva (Engl Ed) [Internet]."},{"issue":"1","key":"10.1016\/j.farma.2024.12.003_bb0090","first-page":"92","article-title":"Depresi\u00f3n y uso de antidepresivos en el paciente cr\u00edtico [Depression and use of antidepressants in the critical patient]","volume":"32","author":"Sandiumenge","year":"2008","journal-title":"Med Intensiva."},{"issue":"3","key":"10.1016\/j.farma.2024.12.003_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2190\/YAYV-U8XA-YEF2-8FM6","article-title":"Depression in intensive care units","volume":"17","author":"Goldman","year":"1987","journal-title":"Int J Psychiatry Med [Internet]."},{"issue":"9","key":"10.1016\/j.farma.2024.12.003_bb0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.12788\/jhm.2814","article-title":"Antidepressant use and depressive symptoms in intensive care unit survivors","volume":"12","author":"Wang","year":"2017","journal-title":"J Hosp Med [Internet]."},{"issue":"5","key":"10.1016\/j.farma.2024.12.003_bb0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.psy.47.5.399","article-title":"Epidemiology of depression and antidepressant therapy after acute respiratory failure","volume":"47","author":"Weinert","year":"2006","journal-title":"Psychosomatics [Internet]."},{"key":"10.1016\/j.farma.2024.12.003_bb0110","article-title":"Predictors of major depressive disorder following intensive care of chronically critically ill patients","volume":"2018","author":"Wintermann","year":"2018","journal-title":"Crit Care Res Pract [Internet]"},{"issue":"1","key":"10.1016\/j.farma.2024.12.003_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0885066616686741","article-title":"Impact of an antipsychotic discontinuation bundle during transitions of care in critically ill patients","volume":"34","author":"D'Angelo","year":"2019","journal-title":"J Intensive Care Med [Internet]."},{"issue":"3","key":"10.1016\/j.farma.2024.12.003_bb0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med [Internet]."}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634324001958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634324001958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:48:18Z","timestamp":1770680898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634324001958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1130634324001958"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2024.12.003","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Prospective observational follow-up study of psychoactive drug treatment initiated in the intensive care unit","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.09.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}